Search research articles
Contact Us
Filters
Showing results (191-200 of 204) with videos related to
Page
of 21
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 7, 2023
MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis
John Mascarenhas, Marina Kremyanskaya, Andrea Patriarca, et al.
International Journal of Environmental Research and Public Health
|
July 10, 2010
A multidisciplinary investigation of a polycythemia vera cancer cluster of unknown origin
Vincent Seaman, Steve M Dearwent, Debra Gable, et al.
Cancer Discovery
|
February 13, 2021
LKB1/<i>STK11</i> Is a Tumor Suppressor in the Progression of Myeloproliferative Neoplasms
Christian Marinaccio, Praveen Suraneni, Hamza Celik, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 10, 2019
Impact of High-Molecular-Risk Mutations on Transplantation Outcomes in Patients with Myelofibrosis
Roni Tamari, Franck Rapaport, Nan Zhang, et al.
Molecular and Cellular Biology
|
July 23, 2025
Loss of Function Mouse Models Reveal a Novel Regulatory Function for ULK1 in Myeloproliferative Neoplasms
Diana Saleiro, Jeremy Q Wen, Markella Zannikou, et al.
Nature
|
May 8, 2024
Mapping genotypes to chromatin accessibility profiles in single cells
Franco Izzo, Robert M Myers, Saravanan Ganesan, et al.
Blood Advances
|
October 26, 2020
Phase 2 study of ruxolitinib and decitabine in patients with myeloproliferative neoplasm in accelerated and blast phase
John O Mascarenhas, Raajit K Rampal, Heidi E Kosiorek, et al.
Blood
|
February 29, 2020
Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis
Lukas Ronner, Nikolai Podoltsev, Jason Gotlib, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2023
A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis
John Mascarenhas, Anna Rita Migliaccio, Heidi Kosiorek, et al.
Blood
|
September 14, 2019
Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea
Abdulraheem Yacoub, John Mascarenhas, Heidi Kosiorek, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 204) with videos related to
Sort By:
Page
of 21
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 7, 2023
MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis
John Mascarenhas, Marina Kremyanskaya, Andrea Patriarca, et al.
International Journal of Environmental Research and Public Health
|
July 10, 2010
A multidisciplinary investigation of a polycythemia vera cancer cluster of unknown origin
Vincent Seaman, Steve M Dearwent, Debra Gable, et al.
Cancer Discovery
|
February 13, 2021
LKB1/<i>STK11</i> Is a Tumor Suppressor in the Progression of Myeloproliferative Neoplasms
Christian Marinaccio, Praveen Suraneni, Hamza Celik, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 10, 2019
Impact of High-Molecular-Risk Mutations on Transplantation Outcomes in Patients with Myelofibrosis
Roni Tamari, Franck Rapaport, Nan Zhang, et al.
Molecular and Cellular Biology
|
July 23, 2025
Loss of Function Mouse Models Reveal a Novel Regulatory Function for ULK1 in Myeloproliferative Neoplasms
Diana Saleiro, Jeremy Q Wen, Markella Zannikou, et al.
Nature
|
May 8, 2024
Mapping genotypes to chromatin accessibility profiles in single cells
Franco Izzo, Robert M Myers, Saravanan Ganesan, et al.
Blood Advances
|
October 26, 2020
Phase 2 study of ruxolitinib and decitabine in patients with myeloproliferative neoplasm in accelerated and blast phase
John O Mascarenhas, Raajit K Rampal, Heidi E Kosiorek, et al.
Blood
|
February 29, 2020
Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis
Lukas Ronner, Nikolai Podoltsev, Jason Gotlib, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2023
A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis
John Mascarenhas, Anna Rita Migliaccio, Heidi Kosiorek, et al.
Blood
|
September 14, 2019
Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea
Abdulraheem Yacoub, John Mascarenhas, Heidi Kosiorek, et al.
Page
of 21